We are live on ! Find out more
IDIX

IDENIX PHARMACEUTICALS INC
IDIX

Delisted

IDIX was delisted on the 5th of August, 2014.

Back to rankings

131 hedge funds and large institutions have $2.78B invested in IDENIX PHARMACEUTICALS INC in 2014 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 38 increasing their positions, 34 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more capital invested

Capital invested by funds: $695M → $2.78B (+$2.09B)

219% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 16

100% more funds holding in top 10

Funds holding in top 10: 3 → 6 (+3)

36% more funds holding

Funds holding: 96 → 131 (+35)

12% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 34

41% less call options, than puts

Call options by funds: $29.7M | Put options by funds: $50.7M

Holders
131
Holders Change
+35
Holders Change %
+36.46%
% of All Funds
3.76%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.17%
New
51
Increased
38
Reduced
34
Closed
16
Calls
$29.7M
Puts
$50.7M
Net Calls
-$21M
Net Calls Change
-$26.5M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$49.3M
2
AQR Capital Management
AQR Capital Management
Connecticut
+$31M
3
Morgan Stanley
Morgan Stanley
New York
+$15.4M
4
Invesco
Invesco
Georgia
+$15.3M
5
Barclays
Barclays
United Kingdom
+$14.1M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$71.1M
2
BCPEM
Bain Capital Public Equity Management
Massachusetts
-$58.8M
3
SCM
Sarissa Capital Management
Connecticut
-$31.8M
4
State Street
State Street
Massachusetts
-$18.8M
5
CAM
Cormorant Asset Management
Massachusetts
-$15.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Manulife (Manufacturers Life Insurance)
76
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.83M -$26.6K -2,551 -3%
AGM
77
Alpine Global Management
New York
$1.74M +$751K +72,013 New
VOYA Investment Management
78
VOYA Investment Management
Georgia
$1.7M -$34.8K -3,338 -5%
HMC
79
Harvard Management Company
Massachusetts
$1.69M +$730K +70,000 New
SO
80
STRS Ohio
Ohio
$1.56M +$619K +59,400 +1,080%
GAI
81
General American Investors
New York
$1.48M -$8.31M -797,610 -93%
Millennium Management
82
Millennium Management
New York
$1.3M +$564K +54,100 New
CI
83
Cowen Inc
New York
$1.23M +$530K +50,815 New
FFH
84
Fairfax Financial Holdings
Ontario, Canada
$1.21M +$525K +50,400 New
AL
85
Airain Ltd
Guernsey
$1.08M +$466K +44,700 New
Credit Agricole
86
Credit Agricole
France
$1.01M +$437K +41,890 New
BG
87
BlackRock Group
United Kingdom
$996K – – –
Group One Trading
88
Group One Trading
Illinois
$915K -$787K -75,522 -67%
PAM
89
Panagora Asset Management
Massachusetts
$902K +$381K +36,574 +4,248%
UBS AM
90
UBS AM
Illinois
$880K -$125K -12,000 -25%
Nomura Holdings
91
Nomura Holdings
Japan
$748K +$324K +31,049 New
AWS
92
Aris Wealth Services
Pennsylvania
$723K – – –
TAM
93
Taurus Asset Management
New York
$723K – – –
Prudential Financial
94
Prudential Financial
New Jersey
$648K +$139K +13,380 +99%
PG
95
PEAK6 Group
Illinois
$569K +$246K +23,600 New
LOM
96
Loeb Offshore Management
New York
$558K +$242K +23,172 New
WFM
97
Wilmington Funds Management
Delaware
$553K +$78.2K +7,500 +49%
NCCM
98
Nine Chapters Capital Management
New Jersey
$470K +$203K +19,500 New
Principal Financial Group
99
Principal Financial Group
Iowa
$443K -$133K -12,779 -41%
FNYS
100
First New York Securities
New York
$431K +$187K +17,900 New
2 3
4
5 6

IDIX Hedge Fund Activity: Q2 2014 in Review

131 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in IDENIX PHARMACEUTICALS INC (IDIX) for Q2 2014, worth a combined $2.78B — up 300% from $695M a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new IDIX positions and 16 closed out — a net gain of 35 holders — while 38 added to existing stakes and 34 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $49.3M. The largest seller was T. Rowe Price Associates, cutting an estimated $71.1M.

  • 131 institutional investors held IDENIX PHARMACEUTICALS INC (IDIX) as of Q2 2014, up from 96 in Q1 2014.
  • Funds reported $2.78B of IDENIX PHARMACEUTICALS INC stock for Q2 2014, up 300% quarter-over-quarter.
  • 51 funds opened new IDENIX PHARMACEUTICALS INC positions in Q2 2014 and 16 closed out, a net change of +35 holders.
  • The largest IDENIX PHARMACEUTICALS INC buyer in Q2 2014 was Fidelity Investments, an estimated $49.3M added.
  • The largest IDENIX PHARMACEUTICALS INC seller in Q2 2014 was T. Rowe Price Associates, an estimated $71.1M sold.

Based on aggregated 13F filings for Q2 2014.